ArticleNature biomedical engineering2026
A deep learning system for non-invasive breast cancer diagnosis with multimodal data.
Article in Nature biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An Efficient Cross-Modal Interaction and Dynamic Fusion Network for Multimodal Breast Ultrasound Diagnosis.Tomography (Ann Arbor, Mich.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors.
Funding
Abstract
Early and accurate diagnosis of breast cancer is critical for minimizing needle biopsies and enhancing patient outcomes and requires effective integration of multimodal information. In this article, we introduce a breast cancer intelligent non-invasive diagnosis system (BINDS) to integrate multimodal medical imaging data for breast cancer risk assessment and subtype classification. BINDS uses a two-stage diagnostic approach to match the clinical workflow, where an initial assessment with ultrasound and/or mammography is performed, followed by a more comprehensive multimodal diagnosis incorporating magnetic resonance imaging. In addition, a new radiology-pathology alignment mechanism is proposed to facilitate extraction of pathology-relevant features from radiological images. BINDS is developed and validated with a diverse dataset of 27,048 participants from 8 centres and 7 public datasets. Importantly, BINDS supports flexible combinations of input modalities during training and validation. Notably, BINDS attains an area under the receiver operating characteristic curve of 0.973, and can assist radiologists in reducing biopsies of benign lesions by up to 32.4%. These findings highlight the potential of BINDS to advance breast cancer diagnosis by enabling precise and adaptable decision-making across diverse clinical scenarios and resource settings.
Identifiers
42157015What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.